FI44670B - - Google Patents

Info

Publication number
FI44670B
FI44670B FI2131/64A FI213164A FI44670B FI 44670 B FI44670 B FI 44670B FI 2131/64 A FI2131/64 A FI 2131/64A FI 213164 A FI213164 A FI 213164A FI 44670 B FI44670 B FI 44670B
Authority
FI
Finland
Application number
FI2131/64A
Other languages
Finnish (fi)
Other versions
FI44670C (fi
Inventor
H Holtermann
S Salvesen
Original Assignee
Nyegaard & Co As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nyegaard & Co As filed Critical Nyegaard & Co As
Publication of FI44670B publication Critical patent/FI44670B/fi
Application granted granted Critical
Publication of FI44670C publication Critical patent/FI44670C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452Solutions, e.g. for injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • GPHYSICS
    • G10MUSICAL INSTRUMENTS; ACOUSTICS
    • G10LSPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
    • G10L15/00Speech recognition
    • G10L15/02Feature extraction for speech recognition; Selection of recognition unit
    • G10L2015/022Demisyllables, biphones or triphones being the recognition units
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/90In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FI642131A 1963-10-23 1964-10-09 Suonensisäisesti annettava röntgenkontrastiainevalmiste. FI44670C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB41842/63A GB1069437A (en) 1963-10-23 1963-10-23 Injectable x-ray contrast media
US34421364A 1964-02-12 1964-02-12

Publications (2)

Publication Number Publication Date
FI44670B true FI44670B (es) 1971-08-31
FI44670C FI44670C (fi) 1971-12-10

Family

ID=26264759

Family Applications (1)

Application Number Title Priority Date Filing Date
FI642131A FI44670C (fi) 1963-10-23 1964-10-09 Suonensisäisesti annettava röntgenkontrastiainevalmiste.

Country Status (13)

Country Link
US (1) US3347746A (es)
AT (1) AT263997B (es)
BE (1) BE654702A (es)
BR (1) BR6463683D0 (es)
CH (1) CH438584A (es)
DE (1) DE1234931B (es)
DK (1) DK109526C (es)
FI (1) FI44670C (es)
FR (1) FR3758M (es)
GB (1) GB1069437A (es)
IT (1) IT1044727B (es)
NL (1) NL152753B (es)
SE (1) SE303829C (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855405A (en) * 1969-11-26 1974-12-17 Squibb & Sons Inc Radiographic contrast composition containing 2{40 ,6{40 -diiodo-dl-thyronine and methods of use thereof
CA1132901A (en) * 1978-07-04 1982-10-05 Fridtjov B. Rakli Aniline x-ray agent and buffer whose ph decreases with temperature
GB9020091D0 (en) * 1990-09-14 1990-10-24 Nycomed As Contrast media
GB2465663A (en) * 2008-11-26 2010-06-02 Ge Healthcare As X-ray contrast agent compositions comprising an iodinated X-ray contrast agent and ethylenediamine-N,N-disuccinic acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2132351A (en) * 1934-07-14 1938-10-04 Winthrop Chem Co Inc Stable aqueous solutions of subtances having an anesthetic effect
US2268915A (en) * 1939-05-27 1942-01-06 Hahnemann Res Foundation Method and material for detoxifying local anesthetics
US2820814A (en) * 1955-03-21 1958-01-21 Schering Corp Polyiodinated 5-aminoisophthalic acids, salts, and esters
US3009952A (en) * 1957-04-17 1961-11-21 Sterling Drug Inc Preparation of halogenated isophthalic acids
US2921884A (en) * 1957-09-30 1960-01-19 Sterling Drug Inc Pharmaceutical compositions
US3033757A (en) * 1959-04-08 1962-05-08 Mallinckrodt Chemical Works X-ray contrast agents
US3175952A (en) * 1963-05-29 1965-03-30 Sterling Drug Inc Aqueous radiopaque solutions containing sodium and calcium ions

Also Published As

Publication number Publication date
AT263997B (de) 1968-08-12
DE1234931B (de) 1967-02-23
BE654702A (es) 1965-02-15
GB1069437A (en) 1967-05-17
FR3758M (fr) 1965-12-13
SE303829B (sv) 1968-09-09
IT1044727B (it) 1980-04-21
CH438584A (de) 1967-06-30
NL6412391A (es) 1965-04-26
DK109526C (da) 1968-05-06
SE303829C (sv) 1972-04-17
FI44670C (fi) 1971-12-10
NL152753B (nl) 1977-04-15
BR6463683D0 (pt) 1973-07-17
US3347746A (en) 1967-10-17

Similar Documents

Publication Publication Date Title
AR142945A1 (es)
FI44670B (es)
AT260747B (es)
BE625828A (es)
BE627151A (es)
BE619061A (es)
BE620325A (es)
BE623117A (es)
BE616967A (es)
BE623162A (es)
BE623220A (es)
BE645891A (es)
BE616247A (es)
BE624811A (es)
BE624982A (es)
BE625136A (es)
BE645568A (es)
BE644529A (es)
BE614220A (es)
BE623490A (es)
BE625825A (es)
BE623315A (es)
BE625880A (es)
BE571209A (es)
BE621517A (es)